Friess Associates LLC Amphastar Pharmaceuticals, Inc. Put Options Transaction History
Friess Associates LLC
- $59.9 Million
- Q2 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
261Shares Held
33.7MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$145 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$58.9 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$53.8 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$39 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$33 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.19B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...